Wed, January 6, 2021

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $185 on, Jan 6th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-185-on-jan-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $175 to $185 on, Jan 6th, 2021.

Raghuram, nor any peers, have made any analyst calls on BTAI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30